FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) today reported its financial results as of and for the three and six months ended June 30, 2008. For the three months ended June 30, 2008, the Company reported a net loss of $9.2 million, or $(0.50) per diluted share, compared to a net loss of $6.4 million, or $(0.35) per diluted share, for the same period in 2007. For the six months ended June 30, 2008, the Company reported net income of $22.1 million, or $1.15 per diluted share, compared to a net loss of $12.1 million, or $(0.69) per diluted share, for the same period in 2007. The Company ended the quarter with $76.1 million of cash and cash equivalents and long-term investments in marketable securities.
